ARCADIS NV EO-,02/ NL0006237562 /
04/06/2024 23:01:01 | Var. +0.45 | Volume | Denaro23:01:01 | Lettera23:01:01 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
60.65EUR | +0.75% | - Fatturato: - |
60.65Quantità in denaro: - | 61.10Quantità in lettera: - | 5.44 bill.EUR | 1.40% | 34.02 |
GlobeNewswire
23:00
TC Energy shareholders approve spinoff of South Bow and elect Board of Directors at the 2024 annual ...
GlobeNewswire
23:00
QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop f...
GlobeNewswire
23:00
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:44
ROSEN, A LEADING NATIONAL FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Befor...
GlobeNewswire
22:44
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Malibu Boats, Inc. Investors to Secure Counsel Before Imp...
GlobeNewswire
22:38
Pennsylvania SFI Implementation Committee Wins Award for Collaborating to Advance Conservation and O...
GlobeNewswire
22:35
Vision Sensing Acquisition Corp. Announces Receipt of a Deficiency Notice from Nasdaq for Failure to...
GlobeNewswire
22:30
Weatherford Signs Memorandum of Understanding with QatarEnergy to Advance Tawteen In-Country Value P...
GlobeNewswire
22:30
Winnebago Industries’ Third Quarter Fiscal 2024 Financial Results Announcement to be made on June 20...
GlobeNewswire
22:30
Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients wi...